Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Scientific Publications

High STI burden among a cohort of adolescents aged 12–19 years in a youth-friendly clinic in South Africa

Read more

Features

IAVI signs lease on new Vaccine Design and Development Lab in Jersey City, NJ

July 10, 2024

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team.

Read more

In The News

Interview: African scientists on course with Lassa vaccine

NTAi News

July 10, 2024

Read more

Features

Unitaid, IAVI, Medicines Patent Pool, and Wellcome publish novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

July 5, 2024

With creativity and commitment, changing the status quo to enable access to promising new technologies is possible.

Read more

Features

World Zoonoses Day 2024: IAVI celebrates progress in Lassa vaccine development

July 5, 2024

A series of publications highlight advancements in countermeasures for Lassa fever, an animal-borne illness.

Read more

Press Releases

Advancing toward a preventative HIV vaccine

July 2, 2024

Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating the rare antibodies needed to fight HIV.

Read more

Scientific Publications

Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

Read more

Podcasts

Meet The Scientist Episode 3: Dr. Elana Van Brakel on IAVI’s TB vaccine program

June 26, 2024

In the latest episode of Meet the Scientist, IAVI’s podcast series, we sat down with Elana Van Brakel, medical director at IAVI in Cape Town, South Africa, to discuss her...
Read more